Patents by Inventor Dalton Tomlinson

Dalton Tomlinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reduced volume formulation of glatiramer acetate and methods of administration
    Patent number: 8920373
    Abstract: The present invention provides an improved injection assisting device wherein the improvement comprises an injection lock indicator located between the first and the second outer shell and the outside of the indicator window, configured to indicate to a user whether the injection locking member is in a locked state, and configured to substantially contrast in color with both the first outer shell and the second outer shell, which first and second outer shells contrast in color with each other, and configured to be substantially shielded from a view of a user in the presence of the predetermined amount of compression force on the second outer shell.
    Type: Grant
    Filed: July 14, 2010
    Date of Patent: December 30, 2014
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Ayelet Altman, Tomer El-Gad, Doris Saltkill, Dalton Tomlinson, Paul Greenhalgh, David George Robinson
  • REDUCED VOLUME FORMULATION OF GLATIRAMER ACETATE AND METHODS OF ADMINISTRATION
    Publication number: 20120232017
    Abstract: A method for reducing frequency of relapses in a human patient afflicted with relapsing-remitting multiple sclerosis (RAMS) comprising administering to the patient 0.5 ml of an aqueous pharmaceutical solution of 20 mg glatiramer acetate and 20 mg mannitol and an injection assisting device for facilitating the administration of the pharmaceutical solution.
    Type: Application
    Filed: July 14, 2010
    Publication date: September 13, 2012
    Inventors: Ayelet Altman, Tomer El-Gad, Doris Saltkill, Dalton Tomlinson, Paul Greenhalgh, David George Robinson